Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
177 | AGER | advanced glycosylation end-product specific receptor | |
207 | AKT1 | AKT serine/threonine kinase 1 | |
288 | ANK3 | ankyrin 3 | |
1116 | CHI3L1 | chitinase 3 like 1 | |
1129 | CHRM2 | cholinergic receptor muscarinic 2 | |
1139 | CHRNA7 | cholinergic receptor nicotinic alpha 7 subunit | |
1268 | CNR1 | cannabinoid receptor 1 | |
1312 | COMT | catechol-O-methyltransferase | |
1501 | CTNND2 | catenin delta 2 | |
1814 | DRD3 | dopamine receptor D3 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
58234 | Shank3 | SH3 and multiple ankyrin repeat domains 3 | |
59287 | Ncstn | nicastrin | |
74342 | Lrrtm1 | leucine rich repeat transmembrane neuronal 1 | |
94109 | Csmd1 | CUB and Sushi multiple domains 1 | |
108071 | Grm5 | glutamate receptor, metabotropic 5 | |
111174 | Taar1 | trace amine-associated receptor 1 | |
216856 | Nlgn2 | neuroligin 2 | |
225207 | Zfp521 | zinc finger protein 521 | |
232333 | Slc6a1 | solute carrier family 6 (neurotransmitter transporter, GABA), member 1 | |
233904 | Setd1a | SET domain containing 1A |
UniProt ID | Protein Name | Source |
---|---|---|
P14842 | 5-hydroxytryptamine receptor 2A | |
P20272 | Cannabinoid receptor 1 | |
P29476 | Nitric oxide synthase 1 |
UniProt ID | Protein Name | Source |
---|---|---|
P30430 | Furin-like protease 1, isoform 1-CRR |
UniProt ID | Protein Name | Source |
---|---|---|
A0A8M9Q738 | Voltage-dependent L-type calcium channel subunit alpha |
HPO ID | HPO Term |
---|---|
HP:0002353 | EEG abnormality |
HP:0000738 | Hallucinations |
HP:0100753 | Schizophrenia |
HP:0000006 | Autosomal dominant inheritance |
HP:0007086 | Social and occupational deterioration |
HP:0000746 | Delusion |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025